Baader Bank Aktiengesellschaft’s CureVac CVAC Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,000	Closed	-$82K	–	348
2023 Q3	$82K	Buy	+12,000	New	+$106K	0.01%	276
2023 Q2	–	Sell	-12,000	Closed	-$83.6K	–	434
2023 Q1	$83.6K	Hold	12,000	–	–	﹤0.01%	325
2022 Q4	$72.4K	Hold	12,000	–	–	﹤0.01%	348
2022 Q3	$94.6K	Hold	12,000	–	–	0.01%	321
2022 Q2	$163K	Hold	12,000	–	–	0.01%	316
2022 Q1	$235K	Buy	+12,000	New	+$240K	0.02%	223

Other funds holding CVAC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Baader Bank Aktiengesellschaft's CVAC Position: Q4 2023 in Review

Baader Bank Aktiengesellschaft sold out of CureVac (CVAC) in Q4 2023, closing a stake of 12,000 shares — an estimated $82K sold.

Baader Bank Aktiengesellschaft first reported a position in CVAC in Q1 2022 and held it in 6 quarters. The position peaked at $235K in Q1 2022. 90 funds tracked by Wall St. Rank hold CVAC as of Q4 2023.

Baader Bank Aktiengesellschaft reported no remaining CureVac position as of Q4 2023 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 12,000 CureVac shares in Q4 2023, an estimated $82K.
Baader Bank Aktiengesellschaft first reported a position in CureVac in Q1 2022 and held it in 6 quarters.
Baader Bank Aktiengesellschaft's CureVac position peaked at $235K in Q1 2022.
90 funds tracked by Wall St. Rank held CureVac as of Q4 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2023, filed 8 Feb 2024.